Berlin (Germany), Germantown, MD (U.S.A.), September 19, 2014 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY), the German-American cancer molecular diagnostics company, will convert its 13,510,892 bearer shares into registered shares effective Monday, September 22, 2014 at a ratio of 1:1.
The conversion, which was resolved by the Annual General Meeting on June 3, 2014, is meant to facilitate direct communication with shareholders and increase transparency of the shareholder structure. The international security identification number (ISIN) and the security code number (WKN) will change in the wake of the conversion. The new WKN will be A11QW5 (previously A1K051) from September 22, 2014, while the ISIN will be DE000A11QW50 (previously DE000A1K0516). The ticker symbol remains unchanged ECX.
– End –
Contact Epigenomics AG
Antje Zeise, Manager IR | PR
Epigenomics AG
Geneststraße 5
10829 Berlin
Tel +49 (0) 30 24345 386
ir@epigenomics.com www.epigenomics.com
For U.S. press inquiries:
Epigenomics, Inc.
20271 Goldenrod Lane, Suite 2027
Germantown, Maryland 20876
pr@epigenomics.com
Help employers find you! Check out all the jobs and post your resume.
